Episode 1: Lessons learned from the ProACT, ProHOSP, and ProREAL studies: The keys to making procalcitonin work in your antimicrobial stewardship program.
This podcast includes an overview of the following:
Procalcitonin and how it's currently used
How antimicrobial stewardship is impacted when a PCT-guided algorithm is followed vs not followed
Value of using procalcitonin in a suspected viral-infected patient
Trends in Bacterial Resistance and New Antibiotic Treatments for Acute Pulmonary Exacerbations in Patients with Cystic Fibrosis
Chronic pulmonary infections in cystic fibrosis patients is an ongoing challenge. The emergence of multi-drug-resistant mucoid organisms, such as Pseudomonas aeruginosa, has further complicated these infections. At the end of the webinar, attendees should be able to:
List problem bacterial pathogens in CF patients and other current resistance trends in this population
Describe challenges with microbiological identification and susceptibility testing of CF pathogens
Identify new antibiotics that may play a role in the treatment of acute pulmonary exacerbations in patients with CF
Due to exposure to antibiotics from an early age, individuals with CF often have drug-resistant organisms colonizing their respiratory tract. With CF patients living well into adulthood, preservation of antimicrobials is essential now more than ever. At the end of the webinar, attendees should be able to:
List the steps and requirements for testing & determining MICs
On The Frontlines: A Webinar Series for Antimicrobial Stewardship Teams
Antimicrobial Stewardship Teams are hard at work on the front lines, and in today's environment, responsible antimicrobial use has never been more important. We recognize that stewardship teams play a critical role in reducing the spread of antimicrobial resistance, so we want to provide a valuable educational resource to arm you with diagnostic data, best practices, and technology. Professional Acknowledgment for Continuing Education (P.A.C.E.®) credits will be offered.
